Altered DNA methylation in liver and adipose tissues derived from individuals with obesity and type 2 diabetes.
Altered DNA methylation in liver and adipose tissues derived from individuals with obesity and type 2 diabetes.
复制标题
DOI:
10.1186/s12881-018-0542-8
复制
发表时间:
2018-02-21
影响因子:
--
通讯作者:
Orozco L
中科院分区:
文献类型:
--
作者:
Barajas-Olmos F;Centeno-Cruz F;Zerrweck C;Imaz-Rosshandler I;Martínez-Hernández A;Cordova EJ;Rangel-Escareño C;Gálvez F;Castillo A;Maydón H;Campos F;Maldonado-Pintado DG;Orozco L
Obesity is a well-recognized risk factor for insulin resistance and type 2 diabetes (T2D), although the precise mechanisms underlying the relationship remain unknown. In this study we identified alterations of DNA methylation influencing T2D pathogenesis, in subcutaneous and visceral adipose tissues, liver, and blood from individuals with obesity. The study included individuals with obesity, with and without T2D. From these patients, we obtained samples of liver tissue (n = 16), visceral and subcutaneous adipose tissues (n = 30), and peripheral blood (n = 38). We analyzed DNA methylation using Illumina Infinium Human Methylation arrays, and gene expression profiles using HumanHT-12 Expression BeadChip Arrays. Analysis of DNA methylation profiles revealed several loci with differential methylation between individuals with and without T2D, in all tissues. Aberrant DNA methylation was mainly found in the liver and visceral adipose tissue. Gene ontology analysis of genes with altered DNA methylation revealed enriched terms related to glucose metabolism, lipid metabolism, cell cycle regulation, and response to wounding. An inverse correlation between altered methylation and gene expression in the four tissues was found in a subset of genes, which were related to insulin resistance, adipogenesis, fat storage, and inflammation. Our present findings provide additional evidence that aberrant DNA methylation may be a relevant mechanism involved in T2D pathogenesis among individuals with obesity. The online version of this article (10.1186/s12881-018-0542-8) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
5.2
作者:
Ma X;Lee P;Chisholm DJ;James DE
通讯作者:
James DE
影响因子:
12.3
作者:
Lokk K;Modhukur V;Rajashekar B;Märtens K;Mägi R;Kolde R;Koltšina M;Nilsson TK;Vilo J;Salumets A;Tõnisson N
通讯作者:
Tõnisson N
影响因子:
64.8
作者:
Kahn, Steven E.;Hull, Rebecca L.;Utzschneider, Kristina M.
通讯作者:
Utzschneider, Kristina M.
影响因子:
4.5
作者:
Dayeh T;Volkov P;Salö S;Hall E;Nilsson E;Olsson AH;Kirkpatrick CL;Wollheim CB;Eliasson L;Rönn T;Bacos K;Ling C
通讯作者:
Ling C
影响因子:
64.8
作者:
Roadmap Epigenomics Consortium;Kundaje A;Meuleman W;Ernst J;Bilenky M;Yen A;Heravi-Moussavi A;Kheradpour P;Zhang Z;Wang J;Ziller MJ;Amin V;Whitaker JW;Schultz MD;Ward LD;Sarkar A;Quon G;Sandstrom RS;Eaton ML;Wu YC;Pfenning AR;Wang X;Claussnitzer M;Liu Y;Coarfa C;Harris RA;Shoresh N;Epstein CB;Gjoneska E;Leung D;Xie W;Hawkins RD;Lister R;Hong C;Gascard P;Mungall AJ;Moore R;Chuah E;Tam A;Canfield TK;Hansen RS;Kaul R;Sabo PJ;Bansal MS;Carles A;Dixon JR;Farh KH;Feizi S;Karlic R;Kim AR;Kulkarni A;Li D;Lowdon R;Elliott G;Mercer TR;Neph SJ;Onuchic V;Polak P;Rajagopal N;Ray P;Sallari RC;Siebenthall KT;Sinnott-Armstrong NA;Stevens M;Thurman RE;Wu J;Zhang B;Zhou X;Beaudet AE;Boyer LA;De Jager PL;Farnham PJ;Fisher SJ;Haussler D;Jones SJ;Li W;Marra MA;McManus MT;Sunyaev S;Thomson JA;Tlsty TD;Tsai LH;Wang W;Waterland RA;Zhang MQ;Chadwick LH;Bernstein BE;Costello JF;Ecker JR;Hirst M;Meissner A;Milosavljevic A;Ren B;Stamatoyannopoulos JA;Wang T;Kellis M
通讯作者:
Kellis M